As pharmaceutical companies give more and more attention to genome editing technologies, the potential for CRISPR to play a role in drug discovery and development is beginning to be realised. We talked to Ricky Trigg from GlaxoSmithKline about the use of CRISPR for target screening
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
Copyright Oxford Global Marketing Limited. All rights reserved.